Eliminates customs uncertainty and currency conversion costs
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): A double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Viros A, Sanchez-Laorden B, Pedersen M, Furney SJ, Rae J, Hogan K et al
In the US, for example, manufacturers have faced multidistrict litigation over alleged links to pancreatic cancer, with plaintiffs claiming inadequate warnings and defective design
Manufactured under stringent quality standards, it is designed for laboratory and scientific research use where precision, stability, and reliable performance are essential
Moreover, semaglutide2 is going generic in Canada, India and China in 2026, so brace for international adoption and black market export rings